ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1153

Differentially Expressed Genes in Males and Females with Ankylosing Spondylitis (AS): Transcriptomics of IL-17-producing Cells in Patients with AS

Chan Mi Lee1, Ricky Chan2, Maricela Haghiac3 and Marina Magrey4, 1University Hospitals, Cleveland, OH, 2Case Western Reserve University, Cleveland, OH, 3Metrohealth Medical Center, Cleveland, OH, 4Case Western Reserve University, University Hospitals, Richfield, OH

Meeting: ACR Convergence 2022

Keywords: Ankylosing spondylitis (AS), Autoinflammatory diseases, gender, TH17 Cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Spondyloarthritis Including PsA – Basic Science Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Unlike most autoimmune diseases, ankylosing spondylitis (AS) is more frequently diagnosed in men (3:1) and with a higher radiographic progression compared to women. Th17 cells have been recognized as key players in AS pathogenesis, and men have a higher Th17 repertoire compared to women. To better understand what other immune pathways are implicated in AS pathogenesis driving this difference, we compared the transcriptome of IL-17-stimulated peripheral blood mononuclear cells (PBMCs) in male and female AS patients.

Methods: Peripheral blood samples (30mL) were obtained from 10 female and 11 male subjects ≥18 years of age with AS based on modified New York diagnostic criteria at the Clinical Research Unit of MetroHealth Medical Center per approved IRB protocol. Isolated PBMCs were stimulated with CytoStim for 4 hrs and processed through IL-17 secretion enrichment kit (Miltenyi Biotec). IL-17-positive cells were counted, and total RNA was extracted using Takara kit (Takara Biotech). Next generation RNA-sequencing (RNA-seq) was performed at Novogene. The data were analyzed using Advaita Bio’s iPathwayGuide, and relative fold (logFC) was calculated using female AS patients as baseline. Genes were identified using a threshold of 0.05 for statistical significance and with absolute log fold change of at least 0.6. Proinflammatory cytokines and genes involved in Th17 differentiation, signaling, and function were identified and assessed based on prior Th17 transcriptome studies using human cells.

Results: The age and disease activity of patients in each gender group were comparable (Table 1). RNA-seq identified 12,893 genes with 2,851 genes with P-values < 0.05. The Principal Component Analysis (PCA; Figure 1) showed distinct patterns of gene expression in male versus female AS. Looking at Th17 inducers, there was no difference in IL-1, 6, 8, 13, 17, 21, 22, 23, or 26, but lower levels of IL-12B in males. Interestingly, receptors of IL-6, 12, 23, TGF-β and PGE2 were down-regulated in males compared to females except for IL-17RC, which was upregulated. Notably, TGF-β, PGE2, and S100 proteins including S100A2, 4, 6, 8, 9, 10, and S100P were highly upregulated in males. Genes involved in Th17 differentiation, notably BATF, SOCS1, NKD2, and ARID5A were elevated in men, while FOXO1, which inhibits RORC, was decreased. Interestingly, genes involved in the differentiation of type 1 regulatory T cells (Tr1) such as AHR and BLIMP1 were significantly downregulated in men (Table 2).

Conclusion: In-depth transcriptomic analysis of the IL-17 producing cells in male versus female AS patients revealed that, consistent with prior findings, males may have a higher propensity to produce Th17 cells by higher levels of Th17-associated transcription factors. Radiographic progression in men may be mediated by S100 proteins and prostaglandins. These findings need to be confirmed by RT-PCR and in larger studies.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: C. Lee, None; R. Chan, None; M. Haghiac, None; M. Magrey, AbbVie, Eli Lilly, Novartis, Pfizer Inc, UCB.

To cite this abstract in AMA style:

Lee C, Chan R, Haghiac M, Magrey M. Differentially Expressed Genes in Males and Females with Ankylosing Spondylitis (AS): Transcriptomics of IL-17-producing Cells in Patients with AS [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/differentially-expressed-genes-in-males-and-females-with-ankylosing-spondylitis-as-transcriptomics-of-il-17-producing-cells-in-patients-with-as/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differentially-expressed-genes-in-males-and-females-with-ankylosing-spondylitis-as-transcriptomics-of-il-17-producing-cells-in-patients-with-as/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology